The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia (Q34548159)

2 August 2017

1 reference

title

The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia (English)

1 reference

2 August 2017

1 reference

Yongkui Jing

1

1 reference

2 August 2017

1 April 2004

1 reference

2 August 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

Leukemia & Lymphoma

1 reference

2 August 2017

45

1 reference

2 August 2017

4

1 reference

2 August 2017

639-648

1 reference

All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study

2 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Retinoic acid resistance in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Studies on the clinical efficacy and pharmacokinetics of low-dose arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia: a comparison with conventional dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

How acute promyelocytic leukaemia revived arsenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Retinoic acid and arsenic synergize to eradicate leukemic cells in a mouse model of acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Application of heavy metal and cytokine for differentiation-inducing therapy in acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001609933

10.1080/10428190310001609933

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

15160934